Ultralife (NASDAQ:ULBI) Downgraded by StockNews.com to “Buy”

StockNews.com cut shares of Ultralife (NASDAQ:ULBIFree Report) from a strong-buy rating to a buy rating in a report issued on Tuesday morning.

Separately, Benchmark boosted their price objective on Ultralife from $12.00 to $13.00 and gave the company a buy rating in a research note on Tuesday, March 5th.

Read Our Latest Stock Analysis on ULBI

Ultralife Trading Down 2.4 %

Ultralife stock opened at $8.81 on Tuesday. The business has a 50-day simple moving average of $8.45 and a two-hundred day simple moving average of $8.32. The company has a market cap of $144.92 million, a P/E ratio of 20.02 and a beta of 1.26. Ultralife has a 52-week low of $3.86 and a 52-week high of $11.85. The company has a quick ratio of 2.02, a current ratio of 3.80 and a debt-to-equity ratio of 0.19.

Ultralife (NASDAQ:ULBIGet Free Report) last released its quarterly earnings results on Thursday, February 15th. The technology company reported $0.18 earnings per share (EPS) for the quarter. The business had revenue of $44.55 million during the quarter. Ultralife had a return on equity of 7.36% and a net margin of 4.54%.

Institutional Trading of Ultralife

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Healthcare of Ontario Pension Plan Trust Fund purchased a new position in Ultralife in the third quarter valued at about $36,000. Citigroup Inc. acquired a new stake in shares of Ultralife during the third quarter worth about $74,000. Victory Capital Management Inc. acquired a new position in Ultralife in the fourth quarter valued at approximately $59,000. Virtu Financial LLC acquired a new position in Ultralife in the fourth quarter valued at approximately $72,000. Finally, Algert Global LLC acquired a new position in Ultralife in the third quarter valued at approximately $106,000. Hedge funds and other institutional investors own 30.68% of the company’s stock.

About Ultralife

(Get Free Report)

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.

See Also

Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.